Invizyne Technologies will start trading on NASDAQ, utilizing enzyme-based technology for biochemical production.

From GlobeNewswire: 2024-11-12 10:52:00

Invizyne Technologies, Inc. will begin trading on the Nasdaq Capital Market under the ticker symbol “IZTC” on November 13, 2024. The company uses cell-free enzyme-based biomanufacturing systems to produce biochemicals like Active Pharmaceutical Ingredients and biofuels. Their SimplePath™ platform aims to efficiently produce a diverse range of chemicals from natural or renewable resources. This technology could open new markets and business opportunities by offering novel and renewable chemical compounds. Invizyne encourages interested parties to visit their website for more information. The company cautions that forward-looking statements are subject to risks and uncertainties beyond their control.



Read more at GlobeNewswire: Invizyne Technologies to Begin Trading on NASDAQ on